1. Home
  2. CAE vs PRAX Comparison

CAE vs PRAX Comparison

Compare CAE & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

HOLD

Current Price

$29.92

Market Cap

10.1B

Sector

N/A

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$319.12

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAE
PRAX
Founded
1947
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
9.6B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
CAE
PRAX
Price
$29.92
$319.12
Analyst Decision
Buy
Strong Buy
Analyst Count
3
15
Target Price
$34.33
$572.13
AVG Volume (30 Days)
724.3K
364.5K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.95
N/A
Revenue Next Year
$2.93
$6,395.88
P/E Ratio
$35.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.36
$26.70
52 Week High
$34.24
$354.87

Technical Indicators

Market Signals
Indicator
CAE
PRAX
Relative Strength Index (RSI) 43.09 52.94
Support Level $28.38 $290.36
Resistance Level $29.71 N/A
Average True Range (ATR) 0.98 17.96
MACD -0.04 -2.64
Stochastic Oscillator 27.04 55.32

Price Performance

Historical Comparison
CAE
PRAX

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: